Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Phibro Animal Health (PAHC) over the last 14 years, with Q4 2025 value amounting to $27.5 million.

  • Phibro Animal Health's Income towards Parent Company rose 76213.5% to $27.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $87.3 million, marking a year-over-year increase of 18975.18%. This contributed to the annual value of $43.5 million for FY2025, which is 22860.81% up from last year.
  • Phibro Animal Health's Income towards Parent Company amounted to $27.5 million in Q4 2025, which was up 76213.5% from $26.5 million recorded in Q3 2025.
  • Phibro Animal Health's 5-year Income towards Parent Company high stood at $27.5 million for Q4 2025, and its period low was -$8.0 million during Q3 2023.
  • Over the past 5 years, Phibro Animal Health's median Income towards Parent Company value was $9.3 million (recorded in 2023), while the average stood at $10.8 million.
  • As far as peak fluctuations go, Phibro Animal Health's Income towards Parent Company crashed by 30785.79% in 2023, and later skyrocketed by 76213.5% in 2025.
  • Quarter analysis of 5 years shows Phibro Animal Health's Income towards Parent Company stood at $17.5 million in 2021, then plummeted by 58.72% to $7.2 million in 2022, then tumbled by 82.33% to $1.3 million in 2023, then surged by 150.0% to $3.2 million in 2024, then surged by 762.14% to $27.5 million in 2025.
  • Its Income towards Parent Company stands at $27.5 million for Q4 2025, versus $26.5 million for Q3 2025 and $12.5 million for Q2 2025.